SynthesisFrontiers in cardiovascular medicine2022
Abatement of potent P2Y12 antagonist-based dual antiplatelet therapy after coronary intervention: A network meta-analysis of randomized controlled trials.
Oumaima El Alaoui El Abdallaoui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled ittrialcites it